ArticleOncoTargets and therapy2018

Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell.

Yiyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.